Joaquín Borrás‐Blasco

1.0k total citations
61 papers, 618 citations indexed

About

Joaquín Borrás‐Blasco is a scholar working on Immunology, Rheumatology and Pharmacology. According to data from OpenAlex, Joaquín Borrás‐Blasco has authored 61 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 18 papers in Rheumatology and 17 papers in Pharmacology. Recurrent topics in Joaquín Borrás‐Blasco's work include Drug-Induced Adverse Reactions (15 papers), Biosimilars and Bioanalytical Methods (12 papers) and Rheumatoid Arthritis Research and Therapies (8 papers). Joaquín Borrás‐Blasco is often cited by papers focused on Drug-Induced Adverse Reactions (15 papers), Biosimilars and Bioanalytical Methods (12 papers) and Rheumatoid Arthritis Research and Therapies (8 papers). Joaquín Borrás‐Blasco collaborates with scholars based in Spain, United States and Switzerland. Joaquín Borrás‐Blasco's co-authors include Andrés Navarro‐Ruiz, Consuelo Borrás, Xavier Cortés, Octavio Dı́ez-Sales, Elvira Mora, J R Molés, María Morant, R Enríquez, Stéphan Martin and Alicia López‐Castellano and has published in prestigious journals such as PLoS ONE, Annals of the Rheumatic Diseases and International Journal of Pharmaceutics.

In The Last Decade

Joaquín Borrás‐Blasco

56 papers receiving 586 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joaquín Borrás‐Blasco Spain 15 172 156 135 110 91 61 618
Wasu Kamchaisatian Thailand 14 120 0.7× 46 0.3× 169 1.3× 97 0.9× 57 0.6× 50 539
Imran Iqbal Pakistan 14 108 0.6× 179 1.1× 37 0.3× 155 1.4× 56 0.6× 33 558
Rukmini Balu United States 8 126 0.7× 71 0.5× 211 1.6× 95 0.9× 38 0.4× 9 466
Susan Flavin United States 13 553 3.2× 221 1.4× 185 1.4× 235 2.1× 32 0.4× 24 1.8k
Laurence Moachon France 10 43 0.3× 101 0.6× 129 1.0× 126 1.1× 53 0.6× 19 587
Claudia Martorell United States 14 75 0.4× 129 0.8× 213 1.6× 598 5.4× 39 0.4× 28 1.3k
C.T. Leonard United Kingdom 18 227 1.3× 61 0.4× 33 0.2× 159 1.4× 26 0.3× 51 1.2k
Bhushan Kumar India 12 168 1.0× 91 0.6× 18 0.1× 91 0.8× 23 0.3× 37 499
Jackson Jm United States 10 44 0.3× 58 0.4× 77 0.6× 80 0.7× 29 0.3× 12 322
C. Ponvert France 18 141 0.8× 194 1.2× 939 7.0× 53 0.5× 183 2.0× 95 1.4k

Countries citing papers authored by Joaquín Borrás‐Blasco

Since Specialization
Citations

This map shows the geographic impact of Joaquín Borrás‐Blasco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joaquín Borrás‐Blasco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joaquín Borrás‐Blasco more than expected).

Fields of papers citing papers by Joaquín Borrás‐Blasco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joaquín Borrás‐Blasco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joaquín Borrás‐Blasco. The network helps show where Joaquín Borrás‐Blasco may publish in the future.

Co-authorship network of co-authors of Joaquín Borrás‐Blasco

This figure shows the co-authorship network connecting the top 25 collaborators of Joaquín Borrás‐Blasco. A scholar is included among the top collaborators of Joaquín Borrás‐Blasco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joaquín Borrás‐Blasco. Joaquín Borrás‐Blasco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Borrás‐Blasco, Joaquín, et al.. (2025). Influencia de la adherencia en el valor de persistencia dentro de la Medicina 6P. Journal of Healthcare Quality Research. 40(4). 101123–101123.
3.
5.
Argüelles‐Arias, Federico, Fernando Bermejo, Joaquín Borrás‐Blasco, et al.. (2022). Cost-effectiveness analysis of ferric carboxymaltose versus iron sucrose for the treatment of iron deficiency anemia in patients with inflammatory bowel disease in Spain. Therapeutic Advances in Gastroenterology. 15. 1098269107–1098269107. 1 indexed citations
6.
Cortés, Xavier, et al.. (2016). Effectiveness of a systematic vaccination program in patients with autoimmune inflammatory disease treated with anti-TNF alpha drugs. Expert Opinion on Biological Therapy. 16(11). 1317–1322. 6 indexed citations
8.
Borrás‐Blasco, Joaquín, et al.. (2014). Economical impact associated with a biological therapy prioritization protocol in patients with rheumatoid arthritis in the Hospital of Sagunto. Expert Opinion on Biological Therapy. 14(11). 1561–1567. 1 indexed citations
9.
Borrás‐Blasco, Joaquín, et al.. (2013). Clinical and economic impact of the use of etanercept 25 mg once weekly in rheumatoid arthritis, psoriatic arthropathy and ankylosing spondylitis patients. Expert Opinion on Biological Therapy. 14(2). 145–150. 14 indexed citations
10.
Borrás‐Blasco, Joaquín, et al.. (2013). Educational session as a tool to increase patient satisfaction of switching etanercept from the prefilled syringe to the autoinjection pen. Expert Opinion on Biological Therapy. 13(8). 1103–1108. 19 indexed citations
11.
Borrás‐Blasco, Joaquín, Andrés Navarro‐Ruiz, Consuelo Borrás, & Elvira Mora. (2009). Adverse Cutaneous Reactions Induced by TNF-α Antagonist Therapy. Southern Medical Journal. 102(11). 1133–1140. 34 indexed citations
12.
Borrás‐Blasco, Joaquín, et al.. (2008). Severe Stomatitis Complicating Treatment With Pegylated-Interferon α-2a and Ribavirin in an HCV-Infected Patient. Southern Medical Journal. 101(1). 88–90. 1 indexed citations
13.
Borrás‐Blasco, Joaquín, et al.. (2008). eptic shock and community-acquired pneumonia associated with etanercept therapy. International Journal of Clinical Pharmacology and Therapeutics. 46(4). 193–197. 7 indexed citations
14.
Borrás‐Blasco, Joaquín, et al.. (2008). Generalised erythematous skin eruptions induced by sorafenib: cutaneous toxicity and treatment outcome. Clinical & Translational Oncology. 10(12). 844–846. 3 indexed citations
15.
Borrás‐Blasco, Joaquín, et al.. (2008). Adverse cutaneous reactions associated with the newest antiretroviral drugs in patients with human immunodeficiency virus infection. Journal of Antimicrobial Chemotherapy. 62(5). 879–888. 60 indexed citations
16.
Borrás‐Blasco, Joaquín, et al.. (2007). Successful desensitization protocol for hypersensitivity reactions caused by oxaliplatin. International Journal of Clinical Pharmacology and Therapeutics. 45(11). 606–610. 4 indexed citations
17.
Borrás‐Blasco, Joaquín, et al.. (2007). Possible delayed onset of osteonecrosis of the jaw in association with zoledronic acid. Journal of Clinical Pharmacy and Therapeutics. 32(6). 651–654. 7 indexed citations
18.
Borrás‐Blasco, Joaquín, et al.. (2007). Unrecognized Delayed Toxic Lithium Peak Concentration in an Acute Poisoning with Sustained Release Lithium Product. Southern Medical Journal. 100(3). 321–323. 7 indexed citations
19.
Borrás‐Blasco, Joaquín, et al.. (2007). Hair Loss Induced by Lopinavir‐Ritonavir. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(8). 1215–1218. 7 indexed citations
20.
Borrás‐Blasco, Joaquín, et al.. (2001). Erythrodermia induced by omeprazole. International Journal of Clinical Pharmacology and Therapeutics. 39(5). 219–223. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026